GLP-1 medications such as Ozempic, Wegovy and Mounjaro are being widely described as wonder drugs for obesity, Type 2 diabetes and cardiovascular risk. For many people, they offer real and meaningful benefits.
But as their use increases in older adults, an important question is being overlooked:
What happens to muscle – and what does that mean for cognitive decline and healthy ageing?
